| 4.2 |
4.2 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 4.2 |
12.6 |
GO:2000064 |
regulation of cortisol biosynthetic process(GO:2000064) |
| 3.6 |
10.7 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 2.9 |
11.7 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 2.2 |
6.5 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 2.0 |
12.1 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 2.0 |
6.0 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 2.0 |
5.9 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 1.9 |
13.1 |
GO:1903019 |
negative regulation of glycoprotein metabolic process(GO:1903019) |
| 1.9 |
9.3 |
GO:0044854 |
membrane raft assembly(GO:0001765) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) membrane assembly(GO:0071709) |
| 1.8 |
14.5 |
GO:0003065 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.6 |
4.8 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 1.6 |
3.2 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 1.5 |
4.6 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.5 |
7.3 |
GO:1903960 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
| 1.4 |
5.8 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 1.4 |
21.6 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 1.4 |
2.8 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 1.3 |
1.3 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
| 1.3 |
20.1 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 1.3 |
8.0 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.3 |
3.8 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 1.2 |
3.7 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 1.2 |
9.8 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 1.2 |
4.9 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 1.2 |
1.2 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 1.2 |
3.6 |
GO:0002514 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 1.2 |
5.9 |
GO:0045989 |
positive regulation of striated muscle contraction(GO:0045989) |
| 1.2 |
3.5 |
GO:0010881 |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
| 1.1 |
4.6 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 1.1 |
3.3 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 1.1 |
5.6 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.1 |
3.3 |
GO:0071476 |
response to vitamin B1(GO:0010266) cellular hypotonic response(GO:0071476) |
| 1.1 |
3.3 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 1.1 |
12.0 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 1.1 |
3.3 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
| 1.1 |
3.2 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 1.1 |
4.3 |
GO:0071071 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) regulation of phospholipid biosynthetic process(GO:0071071) |
| 1.1 |
4.2 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 1.1 |
4.2 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 1.0 |
7.3 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 1.0 |
1.0 |
GO:0010882 |
regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
| 1.0 |
11.1 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.0 |
3.0 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
| 1.0 |
9.0 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.0 |
2.9 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 1.0 |
5.8 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.9 |
9.3 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.9 |
2.7 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.9 |
4.5 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
| 0.9 |
2.7 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.9 |
0.9 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.9 |
5.3 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.9 |
6.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.9 |
6.0 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.9 |
2.6 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.8 |
3.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.8 |
3.3 |
GO:0006927 |
obsolete transformed cell apoptotic process(GO:0006927) |
| 0.8 |
1.6 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.8 |
1.6 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.8 |
2.4 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.8 |
3.1 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.8 |
2.4 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.8 |
2.3 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.8 |
3.1 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.8 |
3.1 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) |
| 0.8 |
0.8 |
GO:0090047 |
obsolete positive regulation of transcription regulator activity(GO:0090047) |
| 0.7 |
8.1 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.7 |
2.2 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.7 |
5.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.7 |
5.1 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.7 |
2.2 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.7 |
2.9 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.7 |
5.0 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.7 |
3.6 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.7 |
2.8 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.7 |
0.7 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
| 0.7 |
0.7 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.7 |
6.3 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.7 |
0.7 |
GO:0060347 |
heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
| 0.7 |
6.9 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.7 |
1.4 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.7 |
0.7 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.7 |
11.5 |
GO:0050812 |
acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.7 |
2.0 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.7 |
18.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.7 |
0.7 |
GO:0045931 |
positive regulation of mitotic cell cycle(GO:0045931) |
| 0.7 |
3.3 |
GO:1903008 |
organelle disassembly(GO:1903008) |
| 0.7 |
5.2 |
GO:0034331 |
cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
| 0.7 |
1.3 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.6 |
3.9 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.6 |
2.6 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.6 |
0.6 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.6 |
1.3 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.6 |
0.6 |
GO:0055098 |
response to low-density lipoprotein particle(GO:0055098) |
| 0.6 |
0.6 |
GO:0045598 |
regulation of fat cell differentiation(GO:0045598) |
| 0.6 |
1.9 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.6 |
5.0 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.6 |
3.1 |
GO:0070884 |
calcineurin-NFAT signaling cascade(GO:0033173) regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.6 |
3.7 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.6 |
1.2 |
GO:0014044 |
Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.6 |
0.6 |
GO:0010915 |
regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.6 |
2.4 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.6 |
3.6 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.6 |
1.2 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.6 |
1.2 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
| 0.6 |
7.1 |
GO:0030041 |
actin filament polymerization(GO:0030041) |
| 0.6 |
1.8 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.6 |
2.4 |
GO:0060209 |
estrus(GO:0060209) |
| 0.6 |
1.2 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.6 |
4.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.6 |
1.7 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.6 |
8.0 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.6 |
1.7 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.6 |
3.9 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.6 |
1.7 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 |
1.1 |
GO:0003159 |
morphogenesis of an endothelium(GO:0003159) |
| 0.6 |
1.7 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.6 |
2.8 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.5 |
6.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.5 |
2.2 |
GO:0034959 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.5 |
1.6 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 |
1.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.5 |
2.2 |
GO:0090594 |
wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
| 0.5 |
0.5 |
GO:0035987 |
endodermal cell fate commitment(GO:0001711) endodermal cell differentiation(GO:0035987) |
| 0.5 |
1.1 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.5 |
1.1 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.5 |
1.1 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.5 |
2.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.5 |
1.1 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.5 |
2.1 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.5 |
2.1 |
GO:0008356 |
asymmetric cell division(GO:0008356) |
| 0.5 |
1.5 |
GO:0043371 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 0.5 |
2.1 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.5 |
0.5 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.5 |
2.5 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.5 |
13.1 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.5 |
0.5 |
GO:0003071 |
renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
| 0.5 |
5.5 |
GO:0060795 |
cell fate commitment involved in formation of primary germ layer(GO:0060795) |
| 0.5 |
2.0 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.5 |
4.9 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.5 |
1.9 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.5 |
3.4 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) negative regulation of cell volume(GO:0045794) |
| 0.5 |
3.4 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.5 |
2.4 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.5 |
2.3 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.5 |
4.2 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.5 |
1.4 |
GO:1903020 |
positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.5 |
1.4 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.5 |
1.4 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.5 |
0.9 |
GO:0021754 |
facial nucleus development(GO:0021754) |
| 0.5 |
2.7 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.5 |
1.8 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.5 |
1.8 |
GO:0060324 |
face development(GO:0060324) |
| 0.4 |
0.4 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.4 |
0.9 |
GO:0002890 |
negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
| 0.4 |
0.9 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.4 |
33.4 |
GO:0008064 |
regulation of actin polymerization or depolymerization(GO:0008064) |
| 0.4 |
2.6 |
GO:0051927 |
obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
| 0.4 |
0.4 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.4 |
0.4 |
GO:0010544 |
regulation of platelet activation(GO:0010543) negative regulation of platelet activation(GO:0010544) |
| 0.4 |
3.5 |
GO:0010737 |
protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
| 0.4 |
1.3 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.4 |
1.3 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.4 |
0.4 |
GO:0051650 |
establishment of vesicle localization(GO:0051650) |
| 0.4 |
3.3 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.4 |
0.8 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.4 |
2.1 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
| 0.4 |
2.1 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.4 |
0.8 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.4 |
1.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.4 |
2.4 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.4 |
1.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.4 |
0.4 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.4 |
0.4 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.4 |
1.6 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.4 |
2.8 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.4 |
1.2 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 |
0.8 |
GO:0032367 |
intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.4 |
0.8 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.4 |
1.9 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.4 |
0.4 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.4 |
4.2 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.4 |
1.1 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.4 |
1.5 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.4 |
0.4 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.4 |
1.9 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.4 |
1.5 |
GO:0002686 |
negative regulation of leukocyte migration(GO:0002686) |
| 0.4 |
0.7 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.4 |
2.6 |
GO:0006896 |
Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
| 0.4 |
1.1 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.4 |
1.1 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.4 |
2.2 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.4 |
1.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.4 |
0.4 |
GO:0016458 |
gene silencing(GO:0016458) |
| 0.4 |
2.1 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.4 |
4.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.4 |
1.8 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.4 |
5.6 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
2.4 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.3 |
1.4 |
GO:0045415 |
negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.3 |
1.0 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 |
1.4 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
2.1 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.3 |
0.3 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.3 |
1.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 |
1.4 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.3 |
0.3 |
GO:1900087 |
traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.3 |
4.1 |
GO:0048488 |
synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
| 0.3 |
0.7 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.3 |
5.9 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.3 |
1.9 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.3 |
1.0 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.3 |
1.0 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
| 0.3 |
1.0 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.3 |
4.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.3 |
0.3 |
GO:0010821 |
regulation of mitochondrion organization(GO:0010821) |
| 0.3 |
1.0 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.3 |
2.5 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.3 |
0.9 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.3 |
2.2 |
GO:0046618 |
drug export(GO:0046618) |
| 0.3 |
1.3 |
GO:0032232 |
negative regulation of actin filament bundle assembly(GO:0032232) |
| 0.3 |
0.6 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.3 |
0.9 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.3 |
3.4 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.3 |
0.9 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.3 |
7.7 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.3 |
0.6 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.3 |
0.9 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 |
2.7 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.3 |
5.7 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.3 |
9.2 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.3 |
0.6 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.3 |
0.9 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
| 0.3 |
0.6 |
GO:0034976 |
response to endoplasmic reticulum stress(GO:0034976) |
| 0.3 |
1.4 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 |
0.6 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.3 |
0.3 |
GO:0070542 |
response to fatty acid(GO:0070542) |
| 0.3 |
1.1 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.3 |
2.3 |
GO:0022410 |
circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.3 |
1.1 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.3 |
0.8 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.3 |
1.4 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.3 |
1.4 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.3 |
8.5 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.3 |
0.8 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) |
| 0.3 |
0.8 |
GO:0042727 |
flavin-containing compound metabolic process(GO:0042726) flavin-containing compound biosynthetic process(GO:0042727) |
| 0.3 |
0.5 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 |
0.5 |
GO:0050665 |
hydrogen peroxide biosynthetic process(GO:0050665) |
| 0.3 |
3.3 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.3 |
1.9 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.3 |
1.4 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.3 |
0.5 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 |
1.6 |
GO:0043312 |
neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.3 |
0.3 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 |
0.5 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.3 |
11.5 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.3 |
1.3 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.3 |
0.3 |
GO:0043534 |
blood vessel endothelial cell migration(GO:0043534) |
| 0.3 |
0.5 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.3 |
0.8 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.3 |
0.8 |
GO:0033059 |
cellular pigmentation(GO:0033059) |
| 0.3 |
0.3 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.3 |
3.1 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.3 |
1.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.3 |
2.5 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.3 |
1.8 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.3 |
1.5 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 |
4.0 |
GO:0048207 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
| 0.2 |
1.5 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.2 |
0.5 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.2 |
0.5 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.2 |
0.7 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
1.0 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.2 |
0.5 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.2 |
0.9 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.2 |
0.5 |
GO:0090178 |
cochlea morphogenesis(GO:0090103) establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.2 |
3.2 |
GO:0033144 |
negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
| 0.2 |
0.5 |
GO:2000243 |
positive regulation of penile erection(GO:0060406) positive regulation of reproductive process(GO:2000243) |
| 0.2 |
0.7 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.2 |
1.4 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
2.7 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.2 |
4.0 |
GO:0030201 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.2 |
0.7 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
2.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.2 |
0.9 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.2 |
0.7 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.2 |
1.1 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.2 |
13.3 |
GO:0034332 |
adherens junction organization(GO:0034332) |
| 0.2 |
0.9 |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.2 |
4.2 |
GO:0008154 |
actin polymerization or depolymerization(GO:0008154) |
| 0.2 |
13.7 |
GO:0006914 |
autophagy(GO:0006914) |
| 0.2 |
0.2 |
GO:0008217 |
regulation of blood pressure(GO:0008217) |
| 0.2 |
2.8 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.2 |
2.4 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
0.4 |
GO:0003208 |
cardiac ventricle morphogenesis(GO:0003208) |
| 0.2 |
1.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 |
1.9 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
1.5 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.2 |
0.6 |
GO:0002263 |
cell activation involved in immune response(GO:0002263) leukocyte activation involved in immune response(GO:0002366) |
| 0.2 |
0.6 |
GO:0034405 |
response to fluid shear stress(GO:0034405) |
| 0.2 |
4.0 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
| 0.2 |
1.0 |
GO:0032909 |
transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.2 |
0.8 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.2 |
5.9 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.2 |
19.4 |
GO:0034329 |
cell junction assembly(GO:0034329) |
| 0.2 |
0.6 |
GO:0002124 |
territorial aggressive behavior(GO:0002124) brainstem development(GO:0003360) vocalization behavior(GO:0071625) |
| 0.2 |
2.3 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.2 |
0.2 |
GO:0097435 |
extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
| 0.2 |
7.5 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.2 |
0.2 |
GO:0009583 |
phototransduction(GO:0007602) detection of light stimulus(GO:0009583) |
| 0.2 |
0.4 |
GO:0060326 |
cell chemotaxis(GO:0060326) |
| 0.2 |
0.6 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.2 |
0.4 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.2 |
0.6 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.2 |
0.8 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
6.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.2 |
3.0 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.2 |
1.6 |
GO:0010226 |
response to lithium ion(GO:0010226) |
| 0.2 |
3.9 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.2 |
1.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
1.0 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 |
0.2 |
GO:0051957 |
positive regulation of amino acid transport(GO:0051957) |
| 0.2 |
0.2 |
GO:0060192 |
negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
| 0.2 |
0.6 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 |
0.4 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.2 |
0.6 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.2 |
1.0 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 |
0.2 |
GO:1903018 |
regulation of glycoprotein metabolic process(GO:1903018) |
| 0.2 |
1.9 |
GO:0017121 |
phospholipid scrambling(GO:0017121) regulation of membrane lipid distribution(GO:0097035) |
| 0.2 |
1.3 |
GO:0055093 |
response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
| 0.2 |
0.6 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.2 |
0.8 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.2 |
0.2 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 |
0.9 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.2 |
0.2 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.2 |
0.9 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.2 |
0.2 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.2 |
0.4 |
GO:0048486 |
parasympathetic nervous system development(GO:0048486) |
| 0.2 |
0.5 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 |
0.9 |
GO:0071674 |
mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.2 |
2.7 |
GO:0001960 |
negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
| 0.2 |
0.7 |
GO:0035295 |
tube development(GO:0035295) |
| 0.2 |
1.1 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
4.1 |
GO:0046464 |
triglyceride catabolic process(GO:0019433) neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.2 |
0.9 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.2 |
9.5 |
GO:0017148 |
negative regulation of translation(GO:0017148) |
| 0.2 |
0.7 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.2 |
0.9 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.2 |
0.3 |
GO:0072273 |
epithelial cell morphogenesis(GO:0003382) metanephric nephron morphogenesis(GO:0072273) |
| 0.2 |
17.1 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.2 |
0.5 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.2 |
0.2 |
GO:0090342 |
regulation of cell aging(GO:0090342) |
| 0.2 |
0.7 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.2 |
0.2 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.2 |
20.9 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.2 |
1.2 |
GO:0009636 |
response to toxic substance(GO:0009636) |
| 0.2 |
0.5 |
GO:0055007 |
cardiac muscle cell differentiation(GO:0055007) |
| 0.2 |
0.2 |
GO:0048048 |
embryonic eye morphogenesis(GO:0048048) |
| 0.2 |
2.3 |
GO:0072595 |
maintenance of protein localization in organelle(GO:0072595) |
| 0.2 |
0.5 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.2 |
0.3 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 |
0.3 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.2 |
0.5 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.2 |
7.3 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.2 |
0.3 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.2 |
0.2 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.2 |
0.5 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.2 |
0.2 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 |
0.6 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.2 |
1.9 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.2 |
0.5 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
0.3 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 |
1.7 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
| 0.2 |
0.6 |
GO:0072164 |
ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
| 0.2 |
0.6 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.2 |
0.3 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.2 |
1.5 |
GO:0061037 |
negative regulation of cartilage development(GO:0061037) |
| 0.2 |
0.3 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.2 |
10.0 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.2 |
2.5 |
GO:0000768 |
syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
| 0.2 |
0.6 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.2 |
4.7 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.2 |
1.4 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
| 0.2 |
0.3 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.2 |
3.2 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.2 |
5.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.6 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.9 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.4 |
GO:0006530 |
asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.1 |
0.4 |
GO:0006561 |
proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
| 0.1 |
1.9 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
| 0.1 |
0.6 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.3 |
GO:0097061 |
dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
| 0.1 |
0.9 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.6 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
1.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.1 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 |
0.4 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.6 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.6 |
GO:0002517 |
T cell tolerance induction(GO:0002517) regulation of tolerance induction(GO:0002643) positive regulation of tolerance induction(GO:0002645) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
| 0.1 |
1.0 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
2.1 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.1 |
0.1 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.3 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.1 |
0.1 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.1 |
3.8 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.1 |
2.1 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.1 |
0.4 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.1 |
1.0 |
GO:0035303 |
regulation of dephosphorylation(GO:0035303) |
| 0.1 |
0.4 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.1 |
0.4 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
| 0.1 |
0.6 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.3 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.3 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.1 |
2.9 |
GO:0007613 |
memory(GO:0007613) |
| 0.1 |
3.1 |
GO:0050818 |
regulation of coagulation(GO:0050818) |
| 0.1 |
0.5 |
GO:0009296 |
obsolete flagellum assembly(GO:0009296) |
| 0.1 |
0.3 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.1 |
0.9 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.4 |
GO:0060253 |
negative regulation of glial cell proliferation(GO:0060253) |
| 0.1 |
0.7 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
0.9 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 |
1.6 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.3 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.1 |
0.9 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.1 |
1.4 |
GO:1902603 |
carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
| 0.1 |
0.4 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.1 |
1.0 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
3.2 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.1 |
1.5 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 |
0.4 |
GO:1904358 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.1 |
4.0 |
GO:0030814 |
regulation of cAMP metabolic process(GO:0030814) |
| 0.1 |
0.3 |
GO:0002220 |
innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
| 0.1 |
1.0 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 |
0.1 |
GO:0042762 |
regulation of sulfur metabolic process(GO:0042762) |
| 0.1 |
0.3 |
GO:0060592 |
mammary gland formation(GO:0060592) |
| 0.1 |
0.2 |
GO:0043588 |
skin development(GO:0043588) |
| 0.1 |
0.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.2 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.1 |
0.5 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
4.8 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
| 0.1 |
0.4 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
1.1 |
GO:0006023 |
aminoglycan biosynthetic process(GO:0006023) |
| 0.1 |
7.0 |
GO:0030198 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.1 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
1.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.6 |
GO:0071731 |
response to nitric oxide(GO:0071731) |
| 0.1 |
0.7 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.1 |
0.1 |
GO:0001993 |
regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
| 0.1 |
1.2 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 |
0.2 |
GO:0034435 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 |
0.6 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.4 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
0.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.2 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.1 |
3.2 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.5 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 |
0.4 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
1.3 |
GO:0002040 |
sprouting angiogenesis(GO:0002040) |
| 0.1 |
22.8 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.1 |
0.5 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.4 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
1.9 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
0.2 |
GO:0030178 |
negative regulation of Wnt signaling pathway(GO:0030178) |
| 0.1 |
0.8 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
1.4 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.1 |
0.1 |
GO:0048532 |
anatomical structure arrangement(GO:0048532) |
| 0.1 |
1.6 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.1 |
0.4 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
1.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
1.3 |
GO:0031175 |
neuron projection development(GO:0031175) |
| 0.1 |
0.3 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.3 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
2.0 |
GO:0046324 |
regulation of glucose import(GO:0046324) |
| 0.1 |
2.0 |
GO:0071772 |
BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
| 0.1 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.5 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.3 |
GO:0032376 |
positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
| 0.1 |
0.2 |
GO:0035051 |
cardiocyte differentiation(GO:0035051) |
| 0.1 |
0.3 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.1 |
0.2 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 |
0.5 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.1 |
0.3 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.1 |
0.6 |
GO:0045446 |
endothelial cell differentiation(GO:0045446) |
| 0.1 |
0.3 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.8 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.1 |
2.1 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.1 |
GO:1903792 |
negative regulation of anion transport(GO:1903792) |
| 0.1 |
1.7 |
GO:0045768 |
obsolete positive regulation of anti-apoptosis(GO:0045768) |
| 0.1 |
0.1 |
GO:0032924 |
activin receptor signaling pathway(GO:0032924) |
| 0.1 |
0.2 |
GO:0060571 |
morphogenesis of an epithelial fold(GO:0060571) |
| 0.1 |
0.2 |
GO:0001503 |
ossification(GO:0001503) |
| 0.1 |
0.3 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
0.2 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 0.1 |
0.8 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.8 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.1 |
0.8 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
| 0.1 |
0.1 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
1.5 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.1 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
1.2 |
GO:0046466 |
sphingolipid catabolic process(GO:0030149) membrane lipid catabolic process(GO:0046466) |
| 0.1 |
0.1 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.7 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.1 |
1.6 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.1 |
0.8 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.1 |
1.5 |
GO:0007015 |
actin filament organization(GO:0007015) |
| 0.1 |
0.8 |
GO:0007128 |
meiotic prophase I(GO:0007128) |
| 0.1 |
0.8 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.3 |
GO:1901998 |
tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
| 0.1 |
4.8 |
GO:0042157 |
lipoprotein metabolic process(GO:0042157) |
| 0.1 |
0.6 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.3 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.1 |
0.3 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
| 0.1 |
0.8 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.4 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
1.5 |
GO:0006937 |
regulation of muscle contraction(GO:0006937) regulation of muscle system process(GO:0090257) |
| 0.1 |
1.1 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.8 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
0.6 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
0.1 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.1 |
3.9 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 |
0.3 |
GO:0035637 |
transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
| 0.1 |
0.3 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
0.1 |
GO:0071603 |
myoblast migration(GO:0051451) endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.5 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.1 |
2.2 |
GO:0030029 |
actin filament-based process(GO:0030029) |
| 0.1 |
1.4 |
GO:0008634 |
obsolete negative regulation of survival gene product expression(GO:0008634) |
| 0.1 |
0.5 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
0.2 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.1 |
0.3 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.6 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.1 |
0.5 |
GO:0007585 |
respiratory gaseous exchange(GO:0007585) |
| 0.1 |
0.4 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.1 |
0.6 |
GO:1901797 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
| 0.1 |
0.4 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
0.1 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.1 |
0.8 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.2 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.1 |
0.2 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
1.2 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.1 |
0.6 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.1 |
0.4 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.1 |
0.4 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
4.2 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
0.4 |
GO:0010976 |
positive regulation of neuron projection development(GO:0010976) |
| 0.1 |
0.1 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.1 |
0.2 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.1 |
1.4 |
GO:0044839 |
G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
| 0.1 |
1.1 |
GO:0006887 |
exocytosis(GO:0006887) |
| 0.1 |
0.2 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 |
17.3 |
GO:0006897 |
endocytosis(GO:0006897) |
| 0.1 |
0.4 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.1 |
GO:0018410 |
C-terminal protein amino acid modification(GO:0018410) |
| 0.1 |
0.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.4 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
0.1 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.1 |
0.7 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.1 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
0.2 |
GO:0001502 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.1 |
0.9 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.1 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.1 |
1.4 |
GO:0036503 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
| 0.1 |
0.1 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.2 |
GO:0051322 |
anaphase(GO:0051322) |
| 0.1 |
0.2 |
GO:0045444 |
fat cell differentiation(GO:0045444) |
| 0.1 |
0.1 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 |
0.3 |
GO:2000108 |
positive regulation of leukocyte apoptotic process(GO:2000108) |
| 0.1 |
0.1 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
0.2 |
GO:0007346 |
regulation of mitotic cell cycle(GO:0007346) |
| 0.1 |
0.7 |
GO:0009584 |
detection of visible light(GO:0009584) |
| 0.1 |
0.3 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
4.8 |
GO:0071559 |
response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.1 |
0.5 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.1 |
GO:0048263 |
determination of dorsal identity(GO:0048263) |
| 0.1 |
0.9 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.1 |
0.2 |
GO:0060178 |
exocyst assembly(GO:0001927) regulation of exocyst assembly(GO:0001928) exocyst localization(GO:0051601) regulation of exocyst localization(GO:0060178) |
| 0.1 |
0.1 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 |
2.1 |
GO:0007623 |
circadian rhythm(GO:0007623) |
| 0.1 |
0.5 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.1 |
0.3 |
GO:0071356 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) cellular response to tumor necrosis factor(GO:0071356) |
| 0.1 |
2.8 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.1 |
0.1 |
GO:0071801 |
podosome assembly(GO:0071800) regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) positive regulation of organelle assembly(GO:1902117) |
| 0.1 |
0.1 |
GO:0007548 |
sex differentiation(GO:0007548) |
| 0.1 |
3.6 |
GO:0006665 |
sphingolipid metabolic process(GO:0006665) |
| 0.1 |
0.1 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
0.1 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.1 |
GO:0051589 |
negative regulation of neurotransmitter transport(GO:0051589) |
| 0.1 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.2 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.3 |
GO:0016577 |
histone demethylation(GO:0016577) |
| 0.1 |
0.4 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.1 |
0.7 |
GO:0050773 |
regulation of dendrite development(GO:0050773) |
| 0.1 |
1.0 |
GO:0006029 |
proteoglycan metabolic process(GO:0006029) |
| 0.1 |
0.4 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 |
1.0 |
GO:0001707 |
mesoderm formation(GO:0001707) |
| 0.1 |
0.8 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.2 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.1 |
1.5 |
GO:1901879 |
regulation of protein depolymerization(GO:1901879) |
| 0.1 |
0.2 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.1 |
0.1 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
0.6 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.1 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.1 |
GO:2000647 |
negative regulation of stem cell proliferation(GO:2000647) |
| 0.1 |
0.2 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.1 |
0.1 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
0.2 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.1 |
0.4 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.3 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.1 |
0.2 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
1.0 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.1 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.1 |
0.6 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.9 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.1 |
0.1 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 |
0.3 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.1 |
0.2 |
GO:0043441 |
acetoacetic acid biosynthetic process(GO:0043441) |
| 0.1 |
0.1 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
| 0.1 |
1.4 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.1 |
0.1 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.1 |
0.4 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.2 |
GO:0017014 |
protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
| 0.1 |
0.2 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.8 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.0 |
GO:0048546 |
digestive tract morphogenesis(GO:0048546) |
| 0.0 |
1.0 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.0 |
0.2 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.4 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.1 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.1 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.0 |
0.3 |
GO:0007507 |
heart development(GO:0007507) |
| 0.0 |
0.1 |
GO:0042476 |
odontogenesis(GO:0042476) |
| 0.0 |
0.0 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.0 |
0.2 |
GO:0015811 |
sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
| 0.0 |
0.1 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.4 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.6 |
GO:0030260 |
entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.0 |
0.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.2 |
GO:0044254 |
angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.3 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 |
0.0 |
GO:1902742 |
apoptotic process involved in development(GO:1902742) |
| 0.0 |
0.5 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.1 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.0 |
0.5 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
2.1 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.0 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
| 0.0 |
0.2 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.0 |
0.2 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.2 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.0 |
0.5 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.0 |
0.6 |
GO:0030216 |
keratinocyte differentiation(GO:0030216) |
| 0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.5 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.3 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
1.6 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.7 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.2 |
GO:0071599 |
otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
| 0.0 |
0.1 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
| 0.0 |
0.1 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.0 |
0.2 |
GO:0006547 |
histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
| 0.0 |
0.1 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.3 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.0 |
0.2 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 |
0.1 |
GO:0048730 |
hair follicle morphogenesis(GO:0031069) epidermis morphogenesis(GO:0048730) |
| 0.0 |
0.1 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.0 |
0.1 |
GO:0048870 |
cell motility(GO:0048870) localization of cell(GO:0051674) |
| 0.0 |
0.1 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.2 |
GO:0018107 |
peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
| 0.0 |
0.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.1 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.0 |
0.1 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.3 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.0 |
0.4 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 |
0.1 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.0 |
0.1 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.0 |
0.4 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 |
0.0 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.5 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.0 |
GO:1902913 |
regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.0 |
0.0 |
GO:0009791 |
post-embryonic development(GO:0009791) |
| 0.0 |
3.1 |
GO:0006936 |
muscle contraction(GO:0006936) |
| 0.0 |
0.0 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.2 |
GO:0071384 |
cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
| 0.0 |
0.1 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.0 |
GO:0051057 |
positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.2 |
GO:0046349 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 0.0 |
0.1 |
GO:0015827 |
aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) leucine import(GO:0060356) |
| 0.0 |
0.0 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.0 |
GO:0018198 |
peptidyl-cysteine modification(GO:0018198) |
| 0.0 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.4 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
| 0.0 |
0.5 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.2 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.1 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
6.2 |
GO:0097485 |
axon guidance(GO:0007411) neuron projection guidance(GO:0097485) |
| 0.0 |
0.0 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 |
0.6 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.1 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
1.9 |
GO:0006754 |
ATP biosynthetic process(GO:0006754) |
| 0.0 |
0.0 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.0 |
0.0 |
GO:0046952 |
cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) ketone body metabolic process(GO:1902224) |
| 0.0 |
0.1 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.1 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.0 |
0.1 |
GO:0002832 |
negative regulation of response to biotic stimulus(GO:0002832) |
| 0.0 |
0.2 |
GO:1901072 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
4.1 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.0 |
GO:0010632 |
regulation of epithelial cell migration(GO:0010632) |
| 0.0 |
0.1 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.2 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.2 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
1.1 |
GO:0035966 |
response to topologically incorrect protein(GO:0035966) |
| 0.0 |
0.1 |
GO:0071214 |
cellular response to abiotic stimulus(GO:0071214) |
| 0.0 |
0.1 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.2 |
GO:0030030 |
cell projection organization(GO:0030030) |
| 0.0 |
0.1 |
GO:0042493 |
response to drug(GO:0042493) |
| 0.0 |
0.1 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 |
0.0 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
| 0.0 |
0.1 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 |
0.1 |
GO:0034694 |
response to prostaglandin(GO:0034694) response to prostaglandin E(GO:0034695) |
| 0.0 |
0.0 |
GO:0002604 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
| 0.0 |
0.3 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.0 |
0.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.0 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.9 |
GO:0006469 |
negative regulation of protein kinase activity(GO:0006469) |
| 0.0 |
2.3 |
GO:0006470 |
protein dephosphorylation(GO:0006470) |
| 0.0 |
0.0 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.2 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.2 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.0 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
| 0.0 |
0.1 |
GO:0051881 |
regulation of mitochondrial membrane potential(GO:0051881) |
| 0.0 |
0.1 |
GO:0052547 |
regulation of peptidase activity(GO:0052547) |
| 0.0 |
0.1 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.0 |
0.3 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.0 |
0.0 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.0 |
0.3 |
GO:0048812 |
neuron projection morphogenesis(GO:0048812) |
| 0.0 |
0.2 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.8 |
GO:0015718 |
monocarboxylic acid transport(GO:0015718) |
| 0.0 |
0.0 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.1 |
GO:0043542 |
endothelial cell migration(GO:0043542) |
| 0.0 |
0.0 |
GO:0060343 |
trabecula formation(GO:0060343) trabecula morphogenesis(GO:0061383) |
| 0.0 |
0.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.1 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 |
0.0 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.0 |
0.0 |
GO:0018243 |
protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.1 |
GO:0045786 |
negative regulation of cell cycle(GO:0045786) |
| 0.0 |
0.1 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.0 |
0.0 |
GO:0051797 |
regulation of hair follicle development(GO:0051797) |
| 0.0 |
0.0 |
GO:0006531 |
aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
| 0.0 |
0.0 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
